Cwm LLC Lowers Stake in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Cwm LLC cut its stake by 54.4%, selling 228,704 shares in Q4 and finishing the period with 191,766 shares of DENTSPLY SIRONA (about $2.19 million).
• Insiders bought stock recently — Director James D. Forbes purchased 5,000 shares and Gregory T. Lucier 15,000 shares; insiders acquired 70,000 shares in the last 90 days, while institutional ownership stands at about 95.7%.
• Analyst views are mixed with a consensus "Hold" and a $14.08 target; Q4 revenue of $961 million topped estimates but EPS of $0.27 narrowly missed, and the company set FY‑2026 guidance of 1.40–1.50 EPS.

Cwm LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 54.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 191,766 shares of the medical instruments supplier's stock after selling 228,704 shares during the quarter. Cwm LLC owned approximately 0.10% of DENTSPLY SIRONA worth $2,192,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in DENTSPLY SIRONA by 109.8% in the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier's stock worth $211,470,000 after acquiring an additional 6,970,086 shares during the period. Armistice Capital LLC lifted its stake in DENTSPLY SIRONA by 1,044.0% in the third quarter. Armistice Capital LLC now owns 5,736,000 shares of the medical instruments supplier's stock worth $72,790,000 after acquiring an additional 5,234,587 shares during the period. Jacobs Levy Equity Management Inc. raised its holdings in DENTSPLY SIRONA by 662.0% in the third quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier's stock worth $58,480,000 after purchasing an additional 4,003,606 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock worth $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Finally, Brickwood Asset Management LLP raised its holdings in DENTSPLY SIRONA by 5,515.8% in the third quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier's stock worth $19,340,000 after purchasing an additional 1,496,935 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director James D. Forbes acquired 5,000 shares of the company's stock in a transaction dated Monday, March 9th. The shares were acquired at an average price of $12.48 per share, with a total value of $62,400.00. Following the purchase, the director directly owned 10,000 shares of the company's stock, valued at $124,800. This trade represents a 100.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gregory T. Lucier acquired 15,000 shares of the company's stock in a transaction dated Monday, March 9th. The shares were purchased at an average cost of $12.45 per share, for a total transaction of $186,750.00. Following the purchase, the director directly owned 65,000 shares in the company, valued at approximately $809,250. This trade represents a 30.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 70,000 shares of company stock worth $956,437 in the last ninety days. Corporate insiders own 0.50% of the company's stock.

Analyst Ratings Changes

XRAY has been the subject of a number of recent research reports. Mizuho boosted their target price on shares of DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a "neutral" rating in a report on Monday, March 2nd. Bank of America upgraded shares of DENTSPLY SIRONA from a "neutral" rating to a "buy" rating and upped their price objective for the company from $13.00 to $17.00 in a report on Thursday, February 19th. Weiss Ratings restated a "sell (d-)" rating on shares of DENTSPLY SIRONA in a report on Monday. Zacks Research upgraded shares of DENTSPLY SIRONA from a "strong sell" rating to a "hold" rating in a report on Monday, March 2nd. Finally, Citigroup started coverage on shares of DENTSPLY SIRONA in a report on Wednesday, April 15th. They set a "sell" rating and a $10.00 price objective on the stock. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Hold" and a consensus target price of $14.08.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $11.91 on Friday. The stock has a 50-day simple moving average of $12.23 and a two-hundred day simple moving average of $12.05. The firm has a market capitalization of $2.38 billion, a P/E ratio of -3.97, a PEG ratio of 1.40 and a beta of 0.99. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $17.18. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.03 and a current ratio of 1.51.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). The company had revenue of $961.00 million during the quarter, compared to analysts' expectations of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The company's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.43 earnings per share for the current year.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc NASDAQ: XRAY is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company's product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.